Tag: GSK

Brian O’Neill, developer of Discovery Labs in King of Prussia, is completing a $1 billion financing package to recapitalize Innovation 411, the life sciences…

GlaxoSmithKline, the London-based pharmaceutical giant with a substantial presence in Montgomery County and Philadelphia, announced a landmark investment of up to $800 million to…

Forbes partnered with Statista — a platform in Germany that provides company insights — to assess diversity, equity, and inclusion (DEI) initiatives nationwide. The analysis yielded insights…

Big Pharma company GSK — which has a multi-site presence in Montgomery County (King of Prussia, Conshohocken, and Collegeville) — has announced its first female CFO…

University of Pennsylvania Professor James Wilson recently signed a five-year renewable deal on behalf of his gene therapy lab to license its manufacturing process…

GlaxoSmithKline, with a research facility in Collegeville, is the latest in a line of pharmaceutical manufacturers that are working on a potential vaccine for the…

GlaxoSmithKline, which has a location in Collegeville, has sold the rights to two of its vaccines to a Denmark biotechnology company in a deal valued…

Richard Heaney and Edmund Campbell, representatives of developer Brian O’Neill, presented to West Conshohocken Borough Council recently details on a redevelopment project it’s…

GlaxoSmithKline has agreed to pay up to $61 million to license, research, and develop a cancer treatment based on Adaptimmune Therapeutics’ T-cell therapy, writes…

After ten years, GlaxoSmithKline is closing its neuroscience research and development site in China and is moving it to the company’s hub in the…

GlaxoSmithKline, which has operations in Upper Merion, has reported a strong immune response in adults aged 65 and older from its shingles vaccine Shingrix, writes…

GlaxoSmithKline, with a location in Collegeville, is the world’s sixth largest pharmaceutical company, and produces well-known products including Aquafresh toothpaste, Breathe Right nasal…

GlaxoSmithKline’s West Campus in Upper Merion has been put under agreement by developer O’Neill Properties Group, write Natalie Kostelni and John George for…

GlaxoSmithKline announced on Monday that it is planning to invest $245 million in upgrading its drug research and discovery hub in Upper Providence Township, writes…

GlaxoSmithKline and The Philadelphia Foundation are issuing a call for applications for the 2017 GSK IMPACT Awards.

This annual awards program recognizes local nonprofit organizations…

Slam dunks, home runs, and field goals all have the same thing in common: the thrill of science in motion.

This summer, students in the…

Drug pricing, regulations, and possible Medicaid price negotiations are among the subjects GlaxoSmithKline’s CEO Andrew Witty recently discussed in a Bloomberg Daybreak: Americas interview…